Showing 2271-2280 of 2652 results for "".
- Over 20,000 Screened for Glaucoma in India and Nigeria Thanks to Joint Initiative, Keep Sighthttps://modernod.com/news/over-20000-screened-for-glaucoma-in-india-and-nigeria-thanks-to-joint-initiative-keep-sight/2478954/Allergan, Sightsavers, and the International Agency for the Prevention of Blindness (IAPB) launched the Keep Sight 2020 video report. The report details the results from the first year of their joint initiative, funded by Allergan, which aims to prevent glaucoma-related vision loss in un
- CooperVision Introduces 2021 Best Practices Honoreeshttps://modernod.com/news/coopervision-introduces-2021-best-practices-honorees/2478943/During a year of unprecedented challenges brought on by the COVID-19 pandemic, eye care practices across the nation have adapted to meet the changing needs of their patients and find ways to not only survive, but thrive. In celebration of 10 such practices, CooperVision announced its 2021 Bes
- UK, Four Other Countries to Fast-Track Vaccines for SARS-CoV-2 Variantshttps://modernod.com/news/uk-four-other-countries-to-fast-track-vaccines-for-sars-cov-2-variants/2478939/A group of regulatory authorities from the UK, Australia, Canada, Singapore and Switzerland issued new rules Thursday aimed at speeding up the development of modified COVID-19 vaccines against emerging SAR-CoV-2 strains. The guidance, developed by the UK’s Medicines and Healthcare products
- Topcon Announces US Launch of the Harmony Glaucoma Modulehttps://modernod.com/news/topcon-announces-us-launch-of-the-harmony-glaucoma-module/2478906/Topcon Healthcare announced it has launched its new Glaucoma Module feature for the Harmony Clinical Data Management Solution. The new Glaucoma Module provides eye care professionals easy access to the information needed to diagnose and manage glaucoma on a single screen. The Hood Dashboar
- PYC Therapeutics Accelerates Its Pipeline of RNA Therapeutics for Ocular Diseaseshttps://modernod.com/news/pyc-therapeutics-accelerates-its-pipeline-of-rna-therapeutics-for-ocular-diseases/2478892/PYC Therapeutics announced updates to its programs and outlined its 2021-2022 corporate objectives. PYC is initially targeting inherited ocular diseases, for which it has three preclinical candidates in development. “This year we are focused on transforming PYC Therapeutics into a U.S.-bas
- Ophthalmic Fundraising Activity Soars in Face of Pandemichttps://modernod.com/news/ophthalmic-fundraising-activity-soars-in-face-of-pandemic/2478884/The ophthalmic market continues to expand and attract funding from investors. There were more deals in 2020 than the two previous years, and transactions totaled $8.6 billion, according to a new Market Scope report. Retina is the largest ophthalmic market sector, driven by a booming pharma
- LION Eye Group Collaborates with OCLI-Spectrum Vision Partnershttps://modernod.com/news/lion-eye-group-collaborates-with-ocli-spectrum-vision-partners/2478878/New York-based LION Eye Group announces it has entered into a collaborative agreement with OCLI-Spectrum Vision Partners (OCLI) for integrated eye care. Terms of the deal were not disclosed. “The collaboration was the result of LION’s effort to engage in high quality med
- Icahn to Push for Changes at Bausch Health After Disclosing Stakehttps://modernod.com/news/icahn-to-push-for-changes-at-bausch-health-after-disclosing-stake/2478869/Activist investor Carl Icahn disclosed in a regulatory filing that he has accumulated a 7.8% stake in Bausch Health, making him the largest single shareholder in the company. According to the filing, Icahn believes Bausch shares are “undervalued,” and that he plans to “engage in
- Akorn Receives FDA Approval for Loteprednol Etabonate Ophthalmic Gel, 0.5%https://modernod.com/news/akorn-receives-fda-approval-for-loteprednol-etabonate-ophthalmic-gel-0-5/2478864/Akorn announced that it received approval of its abbreviated new drug application (ANDA) from the FDA for loteprednol etabonate ophthalmic gel, 0.5%, which is indicated for the treatment of postoperative inflammation and pain following ocular surgery. “We are excited to launch yet an
- Euclid Systems Announces Expansion of Leadership Teamhttps://modernod.com/news/euclid-systems-announces-expansion-of-leadership-team/2478845/Euclid Systems has announced expansion of its leadership team. Joseph Boorady, OD, FAAO, appointed to the position of president and chief executive officer in January 2020, brings over 25 years of experience in the ophthalmic industry as an eye care professional, educational leader, entrepreneur